Abstract
Objectives: To evaluate the total number of surgical procedures for varicose vein treatment performed within the Brazilian Unified Public Health System (SUS) and the Private Health System (PHS) between 2015 and 2023 and to analyze their differences regarding the number of procedures over time, financial investments, and in hospital mortality rates. Materials and Methods: Data on varicose vein surgeries performed between 2015 and 2023 were extracted from the SUS database and the procedural code table provided by the National Supplementary Health Agency (ANS), which reports procedures conducted within the PHS in Brazil. The data included geographic region, number of procedures performed, in hospital mortality (reported only by SUS), and the amount invested by the government and private health insurance providers. Results: A total of 1,266,550 varicose vein surgeries were performed in both public and supplementary healthcare systems in Brazil between 2015 and 2023, with an average surgery rate per 10,000 inhabitants per year of 3.7 in SUS and 14.8 in PHS. The total financial investment amounted to BRL 1,492,310,372.13, with an overall average cost per procedure of BRL 1,240.92. The mean cost per procedure in SUS was BRL 679.50, whereas in PHS, it was BRL 1,632.60 approximately 3.15 times higher than in SUS. A total of 29 in hospital deaths were recorded in SUS after varicose vein surgery, representing an overall mortality rate of 0.005%. Conclusions: A total of 1,266,550 surgeries were performed between 2015 and 2023 for chronic venous disease treatment, with a rate of 6.5 procedures per 10,000 inhabitants per year. In the PHS system, the number of surgeries was four times higher than in SUS, considering the number of procedures per 10,000 inhabitants. The total investment in PHS was 3.15 times greater than in SUS, with an estimated average cost per procedure of BRL 1,632.60. The observed in hospital mortality rate in SUS was 0.005%.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://datasus.saude.gov.br/informacoes-de-saude-tabnet/ This research was approved by the institution's Ethics Committee, which is responsible for its conduction. All data obtained from DATASUS, TabNet, and the PHS (D-TISS) were de-identified, ensuring participant anonymity. As a result, the Institutional Review Board (IRB) granted a waiver for informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos